Research Field
연구분야
연구분야
•home > 연구분야 > 발표논문
발표논문
Inhibition of synovial hyperplasia, rheumatoid T cell activation, and experimental arthritis in mice by sulforaphane, a natural
작성자
pmrc
작성일
2018-05-16 21:36
조회
288
Kong, J. S., Yoo, S. A., Kim, H. S., Kim, H. A., Yea, K., Ryu, S. H., ... & Kim, W. U. (2010). Inhibition of synovial hyperplasia, rheumatoid T cell activation, and experimental arthritis in mice by sulforaphane, a naturally occurring isothiocyanate. Arthritis & Rheumatism, 62(1), 159-170.
IF(2014) : 7.764
Abstract
Objective : To investigate whether sulforaphane (SFN), an isothiocyanate derived from cruciferous vegetables such as broccoli, regulates synoviocyte hyperplasia and T cell activation in rheumatoid arthritis (RA).
Methods : Synoviocyte survival was assessed by MTT assay. The levels of Bcl-2, Bax, p53, and pAkt were determined by Western blot analysis. Cytokine concentrations in culture supernatants from mononuclear cells were analyzed by enzyme-linked immunosorbent assay. The in vivo effects of SFN were examined in mice with experimentally induced arthritis.
Results : SFN induced synoviocyte apoptosis by modulating the expression of Bcl-2/Bax, p53, and pAkt. In addition, nonapoptotic doses of SFN inhibited T cell proliferation and the production of interleukin-17 (IL-17) and tumor necrosis factor α (TNFα) by RA CD4+ T cells stimulated with anti-CD3 antibody. Anti-CD3 antibody–induced increases in the expression of retinoic acid–related orphan receptor γt and T-bet were also repressed by SFN. Moreover, the intraperitoneal administration of SFN to mice suppressed the clinical severity of arthritis induced by injection of type II collagen (CII), the anti-CII antibody levels, and the T cell responses to CII. The production of IL-17, TNFα, IL-6, and interferon-γ by lymph node cells and spleen cells from these mice was markedly reduced by treatment with SFN. Anti-CII antibody–induced arthritis in mice was also alleviated by SFN injection.
Conclusion : SFN was found to inhibit synovial hyperplasia, activated T cell proliferation, and the production of IL-17 and TNFα by rheumatoid T cells in vitro. The antiarthritic and immune regulatory effects of SFN, which were confirmed in vivo, suggest that SFN may offer a possible treatment option for RA.
IF(2014) : 7.764
Abstract
Objective : To investigate whether sulforaphane (SFN), an isothiocyanate derived from cruciferous vegetables such as broccoli, regulates synoviocyte hyperplasia and T cell activation in rheumatoid arthritis (RA).
Methods : Synoviocyte survival was assessed by MTT assay. The levels of Bcl-2, Bax, p53, and pAkt were determined by Western blot analysis. Cytokine concentrations in culture supernatants from mononuclear cells were analyzed by enzyme-linked immunosorbent assay. The in vivo effects of SFN were examined in mice with experimentally induced arthritis.
Results : SFN induced synoviocyte apoptosis by modulating the expression of Bcl-2/Bax, p53, and pAkt. In addition, nonapoptotic doses of SFN inhibited T cell proliferation and the production of interleukin-17 (IL-17) and tumor necrosis factor α (TNFα) by RA CD4+ T cells stimulated with anti-CD3 antibody. Anti-CD3 antibody–induced increases in the expression of retinoic acid–related orphan receptor γt and T-bet were also repressed by SFN. Moreover, the intraperitoneal administration of SFN to mice suppressed the clinical severity of arthritis induced by injection of type II collagen (CII), the anti-CII antibody levels, and the T cell responses to CII. The production of IL-17, TNFα, IL-6, and interferon-γ by lymph node cells and spleen cells from these mice was markedly reduced by treatment with SFN. Anti-CII antibody–induced arthritis in mice was also alleviated by SFN injection.
Conclusion : SFN was found to inhibit synovial hyperplasia, activated T cell proliferation, and the production of IL-17 and TNFα by rheumatoid T cells in vitro. The antiarthritic and immune regulatory effects of SFN, which were confirmed in vivo, suggest that SFN may offer a possible treatment option for RA.